The Effect of Lactoferrin in High Calorie Formula on IL-6 and IL10 in Children With Failure to Thrive and Infection
NCT05289674 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75
Last updated 2022-10-04
Summary
Lactoferrin is an iron-binding glycoprotein of the transferrin family which is expressed and refers to it as a "red protein from milk". It is known that lactoferrin can modulate the overall immune response in inflammatory disorders including modulation of cytokine/ chemokine production and immune regulation that resenting by interleukin (IL)-10. Children with failure to thrive have increase the risk of infectious disease. The mechanism behind this may be due to impaired of immune function, in which pro-inflammation response is increased (IL-1β, IL-6), while IL-10 acted as anti-inflammation response tends to reduces.
High calorie formula (Oral Nutrition Supplement/ONS) are products used for oral nutrition support with the aim of increasing nutritional intake. they are a nutrition treatment option for when nutrition support has been identified beside dietary counselling. ONS are typically used in addition to a normal diet, when diet alone is insufficient to meet daily nutritional requirement due to infection or others. ONS should be treated like medication, ensure they are labelled with the patient's name and provided at the prescribed time. It is well established that nutritional deficiency or inadequate can impair immune function. Growing evidence suggest that for certain nutrients increased intake above currently recommended levels may help optimize immune function including improving the defense function and thus resistance to infection while maintaining tolerance.
This study aims to analize the levels of IL-6 and IL- 10 in children with failure to thrive with infection before and after receiving the intervention of lactoferrin in high-calorie formula milk. This study is an observational study with a pre-, post-test design, with designed total subject is 80. The subject is healthy children with weight faltering aged 1-5 years diagnosed with infection (tuberculosis/TB or urinary tract infection/UTI)
Conditions
- Failure to Thrive
- Infections
Interventions
- DIETARY_SUPPLEMENT
-
High Calorie Formula
The high calorie formula is given as much as 300 kcal/day for 90 days after the subject were diagnosed with tuberculosis (TB) or urinary tract infection (UTI), determine as day 1. the diagnosis were determined by pediatrician. Before the intervention (day 0) and after the intervention (day 61), the subjects were taken the blood by laboratory employee of the private hospital in Surabaya, Indonesia
Sponsors & Collaborators
-
Danone Institute International
collaborator OTHER -
Universitas Airlangga
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 1 Year
- Max Age
- 5 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-10-04
- Primary Completion
- 2022-06-30
- Completion
- 2022-06-30
Countries
- Indonesia
Study Locations
More Related Trials
-
Randomized, Controlled Trial - Lactoferrin Prevention of Diarrhea in Children
NCT00560222 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of the Treatment for Infant Iron Deficiency Anemia by Taking Lactoferrin and Ferralia
NCT03534089 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Recombinant Bovine Lactoferrin (rbLf) in Iron Regulation
NCT06428357 ·Status: COMPLETED ·Phase: NA
-
Study of Yili Lactoferrin ShuHua Milk in the Improvement of Human Immunization
NCT01677702 ·Status: COMPLETED ·Phase: NA
-
Efficacy Study of Multiple Micro Nutrients Supplementation
NCT01840384 ·Status: UNKNOWN ·Phase: NA
-
Lucky Iron Fish Home Fortification of Iron
NCT02341586 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Iron Fortified Complementary Food and IPT of Malaria in Young Children in Côte d'Ivoire
NCT01634945 ·Status: COMPLETED ·Phase: NA
-
Lactoferrin in Treatment of Fe Deficient Anemia In Cirrhosis
NCT04335058 ·Status: UNKNOWN ·Phase: NA
-
Utility of Lactoferrin as an Adjunct Therapeutic Agent for COVID-19
NCT04421534 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
The Role and Effect of Anemia in Children With Pneumonia
NCT02466672 ·Status: COMPLETED
-
Acute vs. Delayed Iron Therapy: Effect on Iron Status, Anemia and Cognition
NCT01093989 ·Status: COMPLETED ·Phase: NA
-
Changes in Microbiota and Iron Status After Iron Fortification of Complementary Foods
NCT01111864 ·Status: COMPLETED ·Phase: NA
-
Prebiotic GOS and Lactoferrin With Iron Supplements
NCT03866837 ·Status: COMPLETED ·Phase: NA
-
Lactoferrin for COVID-19-Induced Taste or Smell Abnormality
NCT05760079 ·Status: WITHDRAWN ·Phase: NA
-
Effect of Cow's Milk Kefir on Short Chain Fatty Acid (SCFA), Haemoglobin, and Ferritin Levels of Anemic Adolescent Girls
NCT06957717 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Zinc, Iron, Vitamin A and Psychosocial Care for Child Growth and Development
NCT02319499 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Study Between Oral Liposomal Iron,Iron Supported Lactoferrin and IV Iron Dextran in CKD Children
NCT05714176 ·Status: UNKNOWN ·Phase: PHASE4
-
Lactoferrin and Lysozyme Supplementation for Long-term Diarrhea Sequelae
NCT05519254 ·Status: RECRUITING ·Phase: PHASE3
-
Utility of Lactoferrin as a Preventive Agent for Healthcare Workers Exposed to COVID-19
NCT04427865 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Baby Iron Bioavailability Study
NCT03754543 ·Status: COMPLETED ·Phase: NA
-
Bovine Lactoferrin and Antibiotic-associated Diarrhoea.
NCT02626104 ·Status: COMPLETED ·Phase: PHASE2
-
Iron Supplement Effect on Child Development
NCT02690675 ·Status: COMPLETED ·Phase: NA
-
Investigation of Iron Uptake From Micronutrient Fortified Powder Versus From Tailored Control in Milk
NCT02254460 ·Status: COMPLETED ·Phase: NA
-
Lactoferrin Efficacy Versus Ferrous Sulfate in Treatment of Patients With Iron Deficiency Anemia
NCT04267653 ·Status: COMPLETED ·Phase: PHASE4
-
Iron Absorption From an Iron-fortified Follow-up Formula With Added Synbiotic or Human Milk Oligosaccharides
NCT04774016 ·Status: COMPLETED ·Phase: NA